Roll of ayurveda medicine in the management of Madhumeha (Diabetes)

A conceptual and comparative clinical study of Madhumehari Churna and Madhumehari Ghrit in the Management of Madhumeha .

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/07/020363

Enrollment

Registered

2019-07-25

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: maadhumehari ghrita MADHUMEHARI CHURNA: 6 gm in bd dose before the meal Intervention2: MADHUMEHARI GHRITA: 5 GM BD BEFORE MEAL,FOR 2 MONTH Control Intervention1: Madhumehari churna: 6 g

Eligibility

Inclusion criteria

Inclusion criteria: 1.Presence of cardinal symptoms of Madhumeha described in Ayurveda texts. 2.Confirmed cases of DM type II on the basis of laboratory investigations. 3.Patients having F.B.S. level ranges between 110 â?? 150 mg/dl and P.P. B.S. between 141 â?? 200 mg/dl.

Exclusion criteria

Exclusion criteria: 1.Patient having age below 20 and above 70 years. 2.Patient suffering from complication of DM. 3.Patient having Type-I DM (IDDM). 4.Patient having Type-II DM with any other serious systemic disease. 5.Patient having a FBS more than 150 mg/dl and PPBS more than 200 mg/dl. 6.Patient with lipid profile not in normal range.

Design outcomes

Primary

Measure	Time frame
To evaluate the effect of Madhumehari Ghrit in the management of madhumehaTimepoint: 2 MONTH	—

Secondary

Measure	Time frame
1.To compare the effect of Madhumehari Ghrit and standard drug Madhumehari churna .Timepoint: 2 MONTH	—

Countries

India

Contacts

Public ContactDR PRADEEP SAROJ

national institute of ayurveda

drkedar01@gmail.com8318802228

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026